Effects of HIV Infection on Arterial Endothelial Function: Results From a Large Pooled Cohort Analysis.


Journal

Arteriosclerosis, thrombosis, and vascular biology
ISSN: 1524-4636
Titre abrégé: Arterioscler Thromb Vasc Biol
Pays: United States
ID NLM: 9505803

Informations de publication

Date de publication:
01 2021
Historique:
pubmed: 18 12 2020
medline: 2 2 2021
entrez: 17 12 2020
Statut: ppublish

Résumé

To determine the effects of HIV serostatus and disease severity on endothelial function in a large pooled cohort study of people living with HIV infection and HIV- controls. Approach and Results: We used participant-level data from 9 studies: 7 included people living with HIV (2 treatment-naïve) and 4 had HIV- controls. Brachial artery flow-mediated dilation (FMD) was measured using a standardized ultrasound imaging protocol with central reading. After data harmonization, multiple linear regression was used to examine the effects of HIV- serostatus, HIV disease severity measures, and cardiovascular disease risk factors on FMD. Of 2533 participants, 986 were people living with HIV (mean 44.4 [SD 11.8] years old) and 1547 were HIV- controls (42.9 [12.2] years old). The strongest and most consistent associates of FMD were brachial artery diameter, age, sex, and body mass index. The effect of HIV+ serostatus on FMD was strongly influenced by kidney function. In the highest tertile of creatinine (1.0 mg/dL), the effect of HIV+ serostatus was strong (β=-1.59% [95% CI, -2.58% to -0.60%], The significant effect of HIV+ serostatus on FMD suggests that people living with HIV are at increased cardiovascular disease risk, especially if they have kidney disease.

Identifiants

pubmed: 33327750
doi: 10.1161/ATVBAHA.120.315435
pmc: PMC7770018
mid: NIHMS1642207
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

512-522

Subventions

Organisme : NHLBI NIH HHS
ID : R21 HL146199
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI068634
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI068636
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI069424
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Circulation. 1987 Jul;76(1 Pt 2):I20-8
pubmed: 3297405
Am J Cardiol. 2009 Jun 1;103(11):1610-5
pubmed: 19463524
J Acquir Immune Defic Syndr. 2017 Aug 15;75(5):568-576
pubmed: 28520615
J Am Coll Cardiol. 2010 May 4;55(18):1988-95
pubmed: 20236788
AIDS Res Hum Retroviruses. 2012 Aug;28(8):793-7
pubmed: 21978287
PLoS One. 2012;7(9):e44454
pubmed: 22970224
Ann Intern Med. 2006 Sep 19;145(6):397-406
pubmed: 16983127
J Clin Endocrinol Metab. 2007 Jul;92(7):2506-12
pubmed: 17456578
BMJ. 2011 Feb 15;342:d548
pubmed: 21325005
Prev Med. 2018 Jun;111:231-234
pubmed: 29550303
J Am Heart Assoc. 2020 Jul 21;9(14):e016263
pubmed: 32674634
Open Forum Infect Dis. 2017 Jan 19;4(1):ofw278
pubmed: 28480270
J Am Coll Cardiol. 2002 Jan 16;39(2):257-65
pubmed: 11788217
Antivir Ther. 2014;19(2):141-7
pubmed: 23985706
Lancet HIV. 2017 Aug;4(8):e349-e356
pubmed: 28501495
AIDS. 2017 Jun 1;31(9):1281-1289
pubmed: 28353539
J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):268-73
pubmed: 19387353
HIV Med. 2010 Feb;11(2):130-6
pubmed: 19682101
JAMA Intern Med. 2013 Apr 22;173(8):614-22
pubmed: 23459863
Lancet HIV. 2017 Aug;4(8):e324-e326
pubmed: 28501496
Diabetes Care. 2007 Nov;30(11):2886-91
pubmed: 17686834
JAMA. 2009 Jul 1;302(1):37-48
pubmed: 19567438
J Am Coll Cardiol. 1995 Nov 1;26(5):1235-41
pubmed: 7594037
Lancet. 2013 Jul 27;382(9889):339-52
pubmed: 23727170
Circulation. 2002 Feb 5;105(5):546-9
pubmed: 11827916
J Am Coll Cardiol. 2008 Aug 12;52(7):569-76
pubmed: 18687253
Clin J Am Soc Nephrol. 2011 Jul;6(7):1700-7
pubmed: 21566114
J Acquir Immune Defic Syndr. 2018 May 1;78(1):62-72
pubmed: 29419568
Heart. 2006 Jan;92(1):110-2
pubmed: 15797933
PLoS Med. 2017 Nov 7;14(11):e1002424
pubmed: 29112958
J Infect Dis. 2016 Oct 15;214(8):1212-20
pubmed: 27485357
J Am Coll Cardiol. 2013 Feb 5;61(5):511-23
pubmed: 23369416
Am Heart J. 2004 Apr;147(4):E18
pubmed: 15077088
JAMA. 2012 Jul 25;308(4):405-6
pubmed: 22820794
Clin Infect Dis. 2016 Jul 15;63(2):249-56
pubmed: 27118787
Clin Infect Dis. 2015 Sep 1;61(5):840-9
pubmed: 25979307
Am J Cardiol. 2000 Jul 15;86(2):207-10
pubmed: 10913483
Nat Rev Nephrol. 2019 Feb;15(2):87-108
pubmed: 30607032
AIDS. 2013 Mar 27;27(6):929-937
pubmed: 23196938
Lancet. 2008 Apr 26;371(9622):1417-26
pubmed: 18387667
Circulation. 2009 Aug 11;120(6):502-9
pubmed: 19635967
AIDS. 2014 May 15;28(8):1181-91
pubmed: 24901259
HIV Clin Trials. 2015 Nov;16(6):228-35
pubmed: 26777795
Clin Infect Dis. 2019 May 17;68(11):1877-1886
pubmed: 30219823
AIDS. 2009 Sep 24;23(15):2021-7
pubmed: 19542863
J Am Coll Cardiol. 2003 May 21;41(10):1769-75
pubmed: 12767663
JAMA. 2012 Jul 25;308(4):379-86
pubmed: 22820791
PLoS One. 2013 Apr 09;8(4):e60852
pubmed: 23593327
Immunity. 2013 Oct 17;39(4):633-45
pubmed: 24138880
Epidemiology. 2019 Jan;30(1):69-74
pubmed: 30273188
Circulation. 2011 Jan 18;123(2):163-9
pubmed: 21200002
Circulation. 2007 May 8;115(18):2390-7
pubmed: 17452608
J Gerontol A Biol Sci Med Sci. 2014 Jul;69(7):833-42
pubmed: 24158766

Auteurs

James H Stein (JH)

Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison (J.H.S., C.E.K.).

Noah Kime (N)

University of Washington Collaborative Health Studies Coordinating Center, Seattle (N.K., J.C.D.).

Claudia E Korcarz (CE)

Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison (J.H.S., C.E.K.).

Heather Ribaudo (H)

Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, MA (H.R.).

Judith S Currier (JS)

Division of Infectious Disease, David Geffen School of Medicine at University of California, Los Angeles (J.S.C.).

Joseph C Delaney (JC)

University of Washington Collaborative Health Studies Coordinating Center, Seattle (N.K., J.C.D.).
College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg (J.C.D.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH